| ［1］ |
Boyle WJ， Simonet W S， Lacey DL. Osteoclast differentiation and activation［J］. Nature， 2003，423（6937）：337-342.
|
| ［2］ |
Henriksen K， Karsdal MA， Martin TJ. Osteoclast-derived coupling factors in bone remodeling ［J］. Calcif Tissue Int，2014，94（1）：88-97.
|
| ［3］ |
Claes L， Recknagel S， Ignatius A. Fracture healing under healthy and inflammatory conditions ［J］. Nat Rev Rheumatol，2012，8（3）：133-143.
|
| ［4］ |
Zainal Ariffin SH， Yamamoto Z， Zainol Abidin IZ， et al.Cellular and molecular changes in orthodontic tooth movement［J］. Scientific World Journal， 2011（11）：1788-1803.
|
| ［5］ |
Costa F， Robiony M， Toro C， et al. Condylar positioning devices for orthognathic surgery： a literature review ［J］. Oral Surg Oral Med Oral Pathol Oral Radiol Endod， 2008，106（2）：179-190.
|
| ［6］ |
Everts V， de Vries TJ， Helfrich MH. Osteoclast heterogeneity：lessons from osteopetrosis and inflammatory conditions ［J］.Biochim Biophys Acta， 2009，1792（8）：757-765.
|
| ［7］ |
Drake MT， Clarke BL， Khosla S. Bisphosphonates： mechanism of action and role in clinical practice ［J］. Mayo Clin Proc，2008，83（9）：1032-1045.
|
| ［8］ |
Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis［J］. J Clin Oncol， 2003，21（22）：4253-4254.
|
| ［9］ |
Tam Y， Kar K， Nowzari H， et al. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates -a presentation of six consecutive cases ［J］. Clin Implant Dent Relat Res， 2014，16（5）：751-761 .
|
| ［10］ |
Pichardo SE， van Merkesteyn JP. Bisphosphonate related osteonecrosis of the jaws： spontaneous or dental origin？ ［J］.Oral Surg Oral Med Oral Pathol Oral Radiol， 2013，116（3）：287-292.
|
| ［11］ |
Everts V， Korper W， Hoeben KA， et al. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases： differences between calvaria and long bone［J］. J Bone Miner Res， 2006，21（9）：1399-1408.
|
| ［12］ |
Everts V， Korper W， Jansen DC， et al. Functional heterogeneity of osteoclasts： matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone［J］. FASEB J， 1999，13（10）：1219-1230.
|
| ［13］ |
Perez-Amodio S， Jansen DC， Schoenmaker T， et al. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity ［J］. Calcif Tissue Int，2006，79（4）：245-254.
|
| ［14］ |
Jansen ID， Mardones P， Lecanda F， et al. Ae2（a，b）-deficient mice exhibit osteopetrosis of long bones but not of calvaria［J］.FASEB J， 2009，23（10）：3470-3481.
|
| ［15］ |
Chaichanasakul T， Kang B， Bezouglaia O， et al. Diverse osteoclastogenesis of bone marrow from mandible versus long bone［J］. J Periodontol， 2014，85（6）：829-36.
|
| ［16］ |
Azari A， Schoenmaker T， de Souza Faloni AP， et al. Jaw and long bone marrow derived osteoclasts differ in shape and their response to bone and dentin ［J］. Biochem Biophys Res Commun， 2011，409（2）：205-210.
|
| ［17］ |
de Souza Faloni AP， Schoenmaker T， Azari A， et al. Jaw and long bone marrows have a different osteoclastogenic potential［J］. Calcif Tissue Int， 2011，88（1）：63-74.
|
| ［18］ |
Hu Y， Ek-Rylander B， Karlström E， et al. Osteoclast size heterogeneity in rat long bones is associated with differences in adhesive ligand specificity ［J］. Exp Cell Res， 2008，314（3）：638-650.
|
| ［19］ |
Vermeer JA， Jansen ID， Marthi M， et al. Jaw bone marrowderived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors［J］. Bone， 2013，57（1）：242-251.
|
| ［20］ |
Yu X， Huang Y， Collin-Osdoby P， et al. CCR1 chemokines promote the chemotactic recruitment， RANKL development，and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts［J］. J Bone Miner Res， 2004，19（12）：2065-2077.
|
| ［21］ |
Li X， Qin L， Bergenstock M， et al. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts ［J］. J Biol Chem， 2007，282（45）：33098-33106.
|
| ［22］ |
Bloemen V， de Vries TJ， Schoenmaker T， et al. Intercellular adhesion molecule-1 clusters during osteoclastogenesis ［J］.Biochem Biophys Res Commun， 2009，385（4）：640-645.
|
| ［23］ |
Walker EC，Poulton IJ，McGregor NE，et al. Sustained RANKL response to parathyroid hormone in oncostatin M receptordeficient osteoblasts converts anabolic treatment to a catabolic effect in vivo［J］. J Bone Miner Res， 2012，27（4）：902-912.
|
| ［24］ |
Shibata-Nozaki T， Ito H， Mitomi H， et al. Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor［J］. Arthritis Rheum， 2011，63（9）：2595-2605.
|
| ［25］ |
Costa-Rodrigues J， Fernandes A， Fernandes MH. Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors ［J］. J Cell Biochem， 2011，112（12）：3704-3713.
|
| ［26］ |
van den Bos T， Speijer D， Bank RA， et al. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption：Special emphasis on collagen［J］. Bone， 2008，43（3）：459-468.
|
| ［27］ |
Long F， Chung UI， Ohba S， et al. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton［J］. Development， 2004，131（6）：1309-1318.
|
| ［28］ |
Liu H， Guo J， Wang L， et al. Distinctive anabolic roles of 1，25-dihydroxyvitamin D （3） and parathyroid hormone in teeth and mandible versus long bones ［J］. J Endocrinol， 2009，203（2）：203-213.
|
| ［29］ |
Kishi T，Hagino H，Kishimoto H，et al. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats： effects of long-term administration， withdrawal， and readministration［J］. Bone， 1998，22（5）：515-522.
|
| ［30］ |
Scott CK， Hightower JA. The matrix of endochondral bone differs from the matrix of intramembranous bone ［J］. Calcif Tissue Int， 1991，49（5）：349-354.
|
| ［31］ |
Kobayashi Y， Goto S， Tanno T， et al. Regional variations in the progression of bone loss in two different mouse osteopenia models［J］. Calcif Tissue Int， 1998，62（5）：426-436.
|
| ［32］ |
Yao Z， Xing L， Qin C， et al. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism ［J］. J Biol Chem，2008，283（15）：9917-9924.
|
| ［33］ |
Andersen TL， del Carmen Ovejero M， Kirkegaard T， et al. A scrutiny of matrix metalloproteinases in osteoclasts： evidence for heterogeneity and for the presence of MMPs synthesized by other cells［J］. Bone， 2004，35（5）：1107-1119.
|
| ［34］ |
Yavropoulou MP，Yovos JG.Osteoclastogenesis--current knowledge and future perspectives ［J］. J Musculoskelet Neuronal Interact，2008，8（3）：204-216.
|
| ［35］ |
Helfrich MH， Ralston SH. Bone research protocols ［M］.Springer， 2003：53-167.
|
| ［36］ |
Alnaeeli M， Park J， Mahamed D， et al. Dendritic cells at the osteo-immune interface： implications for inflammation-induced bone loss［J］. J Bone Miner Res， 2007，22（6）：775-780.
|
| ［37］ |
Alnaeeli M， Teng YT. Dendritic cells differentiate into osteoclasts in bone marrow microenvironment in vivo［J］. Blood，2009，113（1）：264-265.
|
| ［38］ |
Nose M， Yamazaki H， Hagino H， et al. Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients［J］. J Bone Miner Metab， 2009，27（1）：57-65.
|
| ［39］ |
de Vries TJ， Schoenmaker T， Hooibrink B， et al. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts［J］. J Leukoc Biol， 2009，85（6）：919-927.
|